Joint Research Technology definition

Joint Research Technology means all Research Technology that is made, developed or discovered jointly by employees or agents of Targacept or its Affiliates and by employees or agents of APSA or its Affiliates, (a) prior to or during the Research Term or (b) during the Follow-Up Period, but excluding Targacept Technology.
View Source
Joint Research Technology means and include any proprietary processes, trade secrets, trademarks, patents, patentable concepts, ideas or methods, or intellectual property which is the basis for a Joint Research Product and which was developed during and under the Research Plan.
View Source
Joint Research Technology means all information (including without limitation concepts, ideas, trade secrets, data and formulations) and methods (including without limitation the methods and technology listed on Schedule E which may be updated by the Parties in writing from time to time, and other processes, protocols, assays, automated and semi-automated techniques and molecular biology methods) for the research, discovery, production and/or characterization of genes and/or proteins which is developed, acquired or otherwise controlled jointly by the Parties during the Agreement Term, including but not limited to any improvements to Joint Research Technology that is developed, acquired or otherwise controlled jointly by the Parties during the Agreement Term.
View Source

Examples of Joint Research Technology in a sentence

  • APSA agrees to negotiate in good faith with Targacept any further royalty-bearing licenses under such other APSA Patents, APSA Know-How and APSA rights in the Joint Patents and Joint Research Technology as may be useful to Targacept in conducting research and development and commercializing such Compounds for use in the Field.

  • Targacept shall be initially responsible for obtaining, prosecuting and/or maintaining throughout the world Patent Rights in the name of Targacept and APSA covering Joint Research Technology pertaining solely and directly to Nicotinic Compounds and APSA shall be initially responsible for obtaining, prosecuting and/or maintaining throughout the world Patent Rights in the name of Targacept and APSA covering all other Joint Research Technology.

  • Except as otherwise expressly provided in Article 5 and this Section 8.1, the Parties shall jointly own all right, title to and interest in (i) all Joint Research Technology and (ii) all the regulatory and clinical documentation and data for the Territory produced under the Research and Development Plan.

  • This option shall extend to thirty (30) days from the date of delivery to Exactech of a viable, workable prototype of any Joint Research Product or Joint Research Technology.

  • MBI shall have the exclusive right, at its expense and its sole discretion, to prepare and prosecute patent applications, and to maintain and enforce any patents issued thereon, with respect to inventions relating to MBI Research Technology (other than Joint Research Technology Patent Rights).

  • MPI hereby grants to MBI and its Affiliates (other than MPI) a royalty-free, non-exclusive right and license, without the right to grant sublicenses except to Affiliates of MBI, to MPI Research Technology and MPI Research Technology Patent Rights (excluding the Initial Research Technology Patent Rights which are subject to the assignment set forth in Section 2) and MPI's rights in Joint Research Technology and Joint Research Technology Patent Rights, for use by MBI solely in the MBI Core Field.

  • MBI shall not be permitted or authorized to use or practice MPI Research Technology, MPI Research Technology Patent Rights or MPI's rights in Joint Research Technology and Joint Research Technology Patent Rights outside the MBI Core Field except with the written consent of MPI.

  • MPI shall have the exclusive right, at its expense and its sole discretion, to prepare and prosecute patent applications, and to maintain and enforce any patents issued thereon, with respect to inventions relating to MPI Research Technology (other than Joint Research Technology Patent Rights).

  • MBI hereby grants to MPI and its Affiliates (other than MBI) a royalty-free, non-exclusive right and license, without the right to grant sublicenses except to Affiliates of MPI, to MBI Research Technology, MBI Research Technology Patent Rights and MBI's rights in Joint Research Technology and Joint Research Technology Patent Rights for use by MPI solely in the MPI Core Field.